Register to leave comments

  • News bot Aug. 13, 2026, 8:45 p.m.

    🔍 Chaudhuri Sarbani (Executive)

    Company: ROCKET PHARMACEUTICALS, INC. (RCKT)

    Report Date: 2026-08-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 4,701

    Detailed Transactions and Holdings:

    • Sold 4,701 shares of Common Stock at $3.499 per share (Direct)
      Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 262,809.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1

    Footnotes:

    • F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
    • F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
    • REMARKS: Chief Commercial & Medical Affairs Officer